Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

被引:13
|
作者
Voeller, Heinz [1 ,2 ]
Gitt, Anselm [3 ]
Jannowitz, Christina [4 ]
Karoff, Marthin [5 ]
Karmann, Barbara [4 ]
Pittrow, David [6 ]
Reibis, Rona [1 ,7 ]
Hildemann, Steven [4 ,8 ]
机构
[1] Klin See, Dept Cardiol, Rudersdorf, Germany
[2] Univ Potsdam, Rehabil Res Ctr, D-14469 Potsdam, Germany
[3] Heidelberg Univ, Inst Herzinfarktforsch, D-69115 Heidelberg, Germany
[4] MSD Sharp & Dohme GmbH, Med Affairs & Klin Forsch, Haar, Germany
[5] Klin Univ Witten Herdecke, Klin Konigsfeld Deutsch Rentenversicherung Westfa, Witten, Germany
[6] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[7] Cardiol Outpatient Clin, Potsdam, Germany
[8] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 1, Bad Krozingen, Germany
关键词
Cardiac rehabilitation; registry; chronic kidney disease; glomerular filtration rate; dyslipidemia; control rates; risk factor; lipids; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RENAL-FUNCTION; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; EXERCISE;
D O I
10.1177/2047487313482285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) is a frequent comorbidity among elderly patients and those with cardiovascular disease. CKD carries prognostic relevance. We aimed to describe patient characteristics, risk factor management and control status of patients in cardiac rehabilitation (CR), differentiated by presence or absence of CKD. Design and methods: Data from 92,071 inpatients with adequate information to calculate glomerular filtration rate (GFR) based on the Cockcroft-Gault formula were analyzed at the beginning and the end of a 3-week CR stay. CKD was defined as estimated GFR <60 ml/min/1.73 m(2). Results: Compared with non-CKD patients, CKD patients were significantly older (72.0 versus 58.0 years) and more often had diabetes mellitus, arterial hypertension, and atherothrombotic manifestations (previous stroke, peripheral arterial disease), but fewer were current or previous smokers had a CHD family history. Exercise capacity was much lower in CKD (59 vs. 92Watts). Fewer patients with CKD were treated with percutaneous coronary intervention (PCI), but more had coronary artery bypass graft (CABG) surgery. Patients with CKD compared with non-CKD less frequently received statins, acetylsalicylic acid (ASA), clopidogrel, beta blockers, and angiotensin converting enzyme (ACE) inhibitors, and more frequently received angiotensin receptor blockers, insulin and oral anticoagulants. In CKD, mean low density lipoprotein cholesterol (LDL-C), total cholesterol, and high density lipoprotein cholesterol (HDL-C) were slightly higher at baseline, while triglycerides were substantially lower. This lipid pattern did not change at the discharge visit, but overall control rates for all described parameters (with the exception of HDL-C) were improved substantially. At discharge, systolic blood pressure (BP) was higher in CKD (124 versus 121 mmHg) and diastolic BP was lower (72 versus 74 mmHg). At discharge, 68.7% of CKD versus 71.9% of non-CKD patients had LDL-C <100 mg/dl. Physical fitness on exercise testing improved substantially in both groups. When the Modification of Diet in Renal Disease (MDRD) formula was used for CKD classification, there was no clinically relevant change in these results. Conclusion: Within a short period of 3-4 weeks, CR led to substantial improvements in key risk factors such as lipid profile, blood pressure, and physical fitness for all patients, even if CKD was present.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [41] Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation
    Khattab, Ahmed A.
    Knecht, Matthias
    Meier, Bernhard
    Windecker, Stephan
    Schmid, Jean-Paul
    Wilhelm, Matthias
    Saner, Hugo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (05) : 743 - 749
  • [42] Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors
    Price, Anna M.
    Edwards, Nicola C.
    Hayer, Manvir K.
    Moody, William E.
    Steeds, Richard P.
    Ferro, Charles J.
    Townend, Jonathan N.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (07) : 497 - 505
  • [43] Cardiac and Kidney Markers for Cardiovascular Prediction in Individuals With Chronic Kidney Disease The Atherosclerosis Risk in Communities Study
    Matsushita, Kunihiro
    Sang, Yingying
    Ballew, Shoshana H.
    Astor, Brad C.
    Hoogeveen, Ron C.
    Solomon, Scott D.
    Ballantyne, Christie M.
    Woodward, Mark
    Coresh, Josef
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (08) : 1770 - +
  • [44] Low Awareness of Cardiovascular Risk Factor Among Patients Admitted in Cardiac Rehabilitation Unit
    Conte, Maurizio
    Rozza, Francesco
    Fucile, Ilaria
    D'Avino, Giuseppina
    Sorvillo, Gianmario
    De Luca, Nicola
    Mancusi, Costantino
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (03) : 321 - 324
  • [45] Dialysis Treatment Is an Independent Risk Factor for Foot Ulceration in Patients With Diabetes and Stage 4 or 5 Chronic Kidney Disease
    Ndip, Agbor
    Rutter, Martin K.
    Vileikyte, Loretta
    Vardhan, Anand
    Asari, Ashwinbhai
    Jameel, Mehreen
    Tahir, Hassan A.
    Lavery, Lawrence A.
    Boulton, Andrew J. M.
    DIABETES CARE, 2010, 33 (08) : 1811 - 1816
  • [46] Cardiovascular risk factors among patients with chronic kidney disease attending a tertiary hospital in Uganda
    Babua, Christopher
    Kalyesubula, Robert
    Okello, Emmy
    Kakande, Barbara
    Sebatta, Elias
    Mungoma, Michael
    Mondo, Charles Kiiza
    CARDIOVASCULAR JOURNAL OF AFRICA, 2015, 26 (04) : 177 - 180
  • [47] Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study
    Ocak, G.
    Rookmaaker, M. B.
    Algra, A.
    de Borst, G. J.
    Doevendans, P. A.
    Kappelle, L. J.
    Verhaar, M. C.
    Visseren, F. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (01) : 65 - 73
  • [48] Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk
    Verhagen, Chloe
    Janssen, Jolien
    Minderhoud, Crista A.
    van den Berg, Esther
    Wanner, Christoph
    Passera, Anna
    Johansen, Odd Erik
    Biessels, Geert Jan
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (10)
  • [49] Exercise Training and Reduction of Cardiovascular Disease Risk Factors in Patients With Chronic Kidney Disease
    Bronas, Ulf G.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (06) : 449 - 458
  • [50] Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
    Demetria Hubbard
    Lisandro D. Colantonio
    Robert S. Rosenson
    Todd M. Brown
    Elizabeth A. Jackson
    Lei Huang
    Kate K. Orroth
    Stephanie Reading
    Mark Woodward
    Vera Bittner
    Orlando M. Gutierrez
    Monika M. Safford
    Michael E. Farkouh
    Paul Muntner
    Cardiovascular Diabetology, 20